Purdue Pharma Names J. Alan Butcher Senior Vice President of Licensing & Business Development
Stamford, Conn. — Purdue Pharma, a leading specialty pharmaceutical company, today announced that Alan Butcher has joined the company as Senior Vice President of Licensing & Business Development. Alan will have responsibility for all of Purdue’s efforts to acquire or in-license commercial, near-commercial, and development-stage products that would benefit from our patient-focused commercial capabilities.
“We’re bringing aboard a proven leader,” said Purdue President & CEO Mark Timney. “Alan brings valuable new skills and experience to Purdue at a time when business development is a core strategic focus for our firm.”
Alan is a highly experienced pharmaceutical executive, with multiple high-value deals completed throughout his career. Since 2012, he has been Vice President of Business Development at Shire Pharmaceuticals. Alan completed Shire’s first ophthalmic product acquisition through the purchase of SARcode Bioscience and he supported, or led, several other transactions including the acquisition of NPS.
Prior to joining Shire, Alan was Vice President and General Manager of Implant Drug Delivery for Endo Pharmaceuticals. In that role, he was responsible for developing business strategy, P&L management, and the development of product candidates and alternative technologies. He joined Endo as Vice President of Business and Corporate Development in 2007, with responsibility for corporate development, as well as acquisition strategy, analysis, and execution.
From 2002 to 2007, Alan was Director of Worldwide Business Development Transactions at GlaxoSmithKline, where he managed the valuation, negotiation, and execution of intellectual property and product licensing deals. He had entered the Business Development function at Bristol-Myers Squibb in 2000 after holding several positions as a research scientist.
Alan holds a Bachelor’s of Science in Clinical Microbiology and a Master’s of Science in Biology with a concentration in Molecular Biology and Genetics from West Chester University of Pennsylvania. He also is a graduate of Cornell University’s Johnson Graduate School of Management.
About Purdue Pharma
Purdue Pharma and its associated U.S. companies are privately-held pharmaceutical companies known for pioneering research on chronic pain. Headquartered in Stamford, CT, Purdue is engaged in the research, development, production, and distribution of both prescription and over-the-counter medicines and hospital products. Additional information about Purdue can be found at www.purduepharma.com.
|James HeinsSenior Director, Public Affairsoffice: 203-588-8069
|Juliana GittlerAssociate Director, Corporate Communicationsoffice: 203-588-7223